학술논문

Rationale and design of the Apixaban for the Reduction of Thrombo-Embolism in Patients With Device-Detected Sub-Clinical Atrial Fibrillation (ARTESiA) trial
Document Type
Article
Source
In: American Heart Journal. (American Heart Journal, 1 July 2017, 189:137-145)
Subject
Language
English
ISSN
10976744
00028703